MASI.NASDAQMasimo CORP

Form 4: Masimo Corporation Acquired by Danaher for $180 Per Share

Sentiment:

Merger Completion / Insider Transaction


Director Darlene J. Solomon reports the disposal of Masimo Corporation common stock and RSUs following the company's acquisition by Danaher Corporation.

Summary

  • Masimo Corporation completed a merger with a subsidiary of Danaher Corporation on June 10, 2026.
  • Director Darlene J. Solomon disposed of 3,015 shares of common stock at a price of $180.00 per share.
  • The director also disposed of 1,119 restricted stock units (RSUs), which were converted into the right to receive $180.00 per share in cash.
  • Following the merger, Masimo Corporation is now a wholly owned subsidiary of Danaher Corporation.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing confirming the completion of a previously announced merger.

Positives

  • Shareholders received a cash consideration of $180.00 per share for their holdings.
  • The transaction represents a definitive exit event for equity holders at a fixed valuation.

Negatives

  • The company is no longer an independent publicly traded entity.

Risks

  • No ongoing risks as the company has been acquired and is now a private subsidiary.

Future Outlook

The company is now a wholly owned subsidiary of Danaher Corporation; no further independent public guidance is provided.

Industry Context

StockSavvy.ai notes that this acquisition aligns with broader consolidation trends in the medical technology sector, where larger conglomerates like Danaher are aggressively acquiring specialized health-tech firms to expand their diagnostic and monitoring portfolios.

Comparison to Industry Standards

  • The $180 per share cash-out represents a significant liquidity event for investors, consistent with premium acquisition multiples seen in recent med-tech M&A activity.
  • The structure of the deal follows standard practice for all-cash acquisitions of publicly traded medical device companies.

Stakeholder Impact

  • Shareholders have been cashed out at $180 per share.
  • Employees and operations are now integrated under Danaher Corporation.

Next Steps

  • Delisting of Masimo Corporation common stock from public exchanges.

Key Dates

DateDescription
2026-02-16Date of the Agreement and Plan of Merger.
2026-04-23Grant date of the restricted stock units.
2026-06-10Effective date of the merger and transaction date.
2026-06-12Date of filing.

Keywords

Masimo, Danaher, Merger, Acquisition, Form 4, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.